Key facts
- This page summarizes Timothy S. Huval's Form 4 filing for HUMANA INC (HUM).
- 2 reported transactions and 7 derivative rows are listed below.
- Accepted by SEC: 03 Jan 2025, 10:51.
Timothy S. Huval - 31 Dec 2024 Form 4 Insider Report for HUMANA INC (HUM)
- Reporting relationship
- Chief Administrative Officer
- Issuer ticker
- HUM
- Reported as of
- 31 Dec 2024
- Net transaction value
- -$948,925
- SEC form
- 4
- Accepted by SEC
- 03 Jan 2025, 10:51:16 UTC
- Prior SEC filing
- 17 Dec 2024
- Next SEC filing
- 22 May 2025
- Source filing
- View source filing
- Reporting owner signature
- Timothy S. Huval
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Timothy S. Huval filed Form 4 for HUMANA INC (HUM) on 03 Jan 2025.
Change
- Previous filing in this sequence was filed on 17 Dec 2024.
- Current net transaction value: -$948,925.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HUM
transaction
Humana Common
Sale
- Transaction value
- $948,925
- Shares
- -3,703
- Change %
- -31%
- Price
- $256.26
- Shares after
- 8,181
- Date
- 31 Dec 2024
- Ownership
- Direct
- Footnotes
- F10
HUM
transaction
Humana Common
Gift
- Transaction value
- $0
- Shares
- -1,070
- Change %
- -13%
- Price
- $0.000000
- Shares after
- 7,111
- Date
- 31 Dec 2024
- Ownership
- Direct
- Footnotes
- F9, F11
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 324
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 324
- Exercise price
- $307.96
- Footnotes
- F1
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,030
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 2,030
- Exercise price
- $350.79
- Footnotes
- F2
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,336
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 3,336
- Exercise price
- $376.61
- Footnotes
- F3
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,932
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 3,932
- Exercise price
- $425.06
- Footnotes
- F4
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,973
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 3,973
- Exercise price
- $510.24
- Footnotes
- F5
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,309
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 6,309
- Exercise price
- $367.21
- Footnotes
- F6
HUM
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 343
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 343
- Exercise price
- Footnotes
- F7, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Timothy S. Huval is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 11 footnotes
Footnote F1
Right to buy pursuant to the Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/19, vesting in three increments from 02/25/20 to 02/25/22.
Footnote F2
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
Footnote F3
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
Footnote F4
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
Footnote F5
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
Footnote F6
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
Footnote F7
Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
Footnote F8
Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
Footnote F9
Includes 3,813 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
Footnote F10
All shares sold at reported price.
Footnote F11
Shares disposed of represent gift/charitable donation in which no value was received in return.